Commodore Capital LP Kura Oncology, Inc. Transaction History

Commodore Capital LP

$1.18 Billion
Q3 2024

A detailed history of Commodore Capital LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Commodore Capital LP holds 1,800,000 shares of KURA stock, worth $28.6 Million. This represents 2.99% of its overall portfolio holdings.

Number of Shares

1,800,000

Previous 1,593,350 12.97%

Holding current value

$28.6 Million

Previous $32.8 Million 7.21%

% of portfolio

2.99%

Previous 2.94%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$18.57 - $23.23 $3.84 Million - $4.8 Million	206,650 Added 12.97%	1,800,000 $35.2 Million
Q2 2024 Aug 14, 2024	BUY	$17.53 - $22.98 $1.2 Million - $1.57 Million	68,350 Added 4.48%	1,593,350 $32.8 Million
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $3.72 Million - $6.52 Million	276,938 Added 22.19%	1,525,000 $32.5 Million
Q4 2023 Feb 14, 2024	SELL	$7.58 - $14.38 $1.15 Million - $2.18 Million	-151,938 Reduced 10.85%	1,248,062 $17.9 Million
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $1.88 Million - $2.73 Million	195,042 Added 16.19%	1,400,000 $14.8 Million
Q1 2023 May 15, 2023	BUY	$10.71 - $14.6 $1.13 Million - $1.54 Million	105,551 Added 9.6%	1,204,958 $14.7 Million
Q4 2022 Feb 14, 2023	BUY	$11.23 - $16.9 $2.25 Million - $3.38 Million	200,000 Added 22.24%	1,099,407 $13.6 Million
Q3 2022 Nov 14, 2022	SELL	$12.01 - $19.45 $11.1 Million - $18 Million	-927,084 Reduced 50.76%	899,407 $12.3 Million
Q2 2022 Aug 15, 2022	BUY	$10.71 - $18.33 $11.2 Million - $19.2 Million	1,049,977 Added 135.22%	1,826,491 $33.5 Million
Q1 2022 May 16, 2022	BUY	$11.78 - $16.98 $9.15 Million - $13.2 Million	776,514 New	776,514 $12.5 Million
Q4 2021 Feb 14, 2022	SELL	$12.22 - $19.57 $12.2 Million - $19.6 Million	-999,433 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $5.83 Million - $8.21 Million	377,940 Added 60.81%	999,433 $18.7 Million
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $2.08 Million - $2.99 Million	99,938 Added 19.16%	621,493 $13 Million
Q1 2021 May 17, 2021	BUY	$24.75 - $39.14 $9.6 Million - $15.2 Million	388,052 Added 290.67%	521,555 $14.7 Million
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $3.87 Million - $5.56 Million	133,503 New	133,503 $4.36 Million

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.06B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Commodore Capital LP with notifications on news.

Account

Commodore Capital LP Kura Oncology, Inc. Transaction History